Ståle Pallesen
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Ståle Pallesen has a total of 72 co-authors. Here are the top co-authors by number of shared publications:
Bjørn Bjorvatn
Haukeland University Hospital
8 shared publications- Børge Sivertsen
Department of Health Promotion, Norwegian Institute of Public Health, Bergen, Norway
6 shared publications - Dominic Sagoe
University of Bergen
5 shared publications Inger Hilde Nordhus
Norwegian Competence Center for Sleep Disorders, Jonas Lies vei 65, 5021 Bergen, Norway; Department of Clinical Psychology, University of Bergen, P.O. Box 7807, N-5020 Bergen, Norway
5 shared publications- Cecilie Schou Andreassen
Department of Psychosocial Science, University of Bergen, Bergen, Norway
4 shared publications - Bjørn Bjorvatn
Department of Global Public Health and Primary Care University of Bergen Bergen Norway
3 shared publications
Latest Publications
- 1 December 2015
- Published by Springer Nature in Sleep and Biological Rhythms
- Vol. 14 (1) , 97-105
A new light source (Valkee©) does not alter sleep–wake parameters and does not improve mood in phase delayed subjects
- 1 December 2015
- Published by Springer Nature in Sleep and Biological Rhythms
- Vol. 14 (1) , 97-105
A new light source (Valkee©) does not alter sleep–wake parameters and does not improve mood in phase delayed subjects
- Open Access
- 2 July 2015
- Published by Taylor & Francis in Scandinavian Journal of Hospitality and Tourism
- Vol. 16 (3) , 243-253
“I Wish I'd Slept Better in That Hotel” – Guests’ Self-reported Sleep Patterns in Hotels
The aim of the present study was to investigate how hotel guests sleep and the factors that typically disturb sleep when staying in hotels. A total of 2504 respondents for the survey were recruited through a link in a national online newspaper. They were asked to provide information about demographics, how they slept in hotels, factors disturbing sleep in hotels and how sleep typically developed with length of stay in hotels. On average, the respondents reported sleeping somewhat less well in hotels than at home. Males, younger people and people suffering from insomnia reported better sleep in hotels than did females, older people and subjects not suffering from insomnia, respectively. The factor which most frequently disturbed sleep in hotels was poor pillows, followed by high room temperature, poor mattress, poor duvet, noise from the street, poor indoor climate, too much daylight from the windows and noise from the ventilation system. Nearly 50% of the respondents reported that sleep usually improved with length of stay, whereas only 8.4% reported that sleep deteriorated with length of stay. The results point to several factors which could be altered by simple means and thereby improve sleep in hotels. The present study is the first large-scale survey that investigates how hotel guests in general experience sleep in hotels.
- 2 July 2015
- Published by Taylor & Francis in Scandinavian Journal of Hospitality and Tourism
- Vol. 16 (3) , 243-253
Open Access“I Wish I'd Slept Better in That Hotel” – Guests’ Self-reported Sleep Patterns in Hotels
The aim of the present study was to investigate how hotel guests sleep and the factors that typically disturb sleep when staying in hotels. A total of 2504 respondents for the survey were recruited through a link in a national online newspaper. They were asked to provide information about demographics, how they slept in hotels, factors disturbing sleep in hotels and how sleep typically developed with length of stay in hotels. On average, the respondents reported sleeping somewhat less well in hotels than at home. Males, younger people and people suffering from insomnia reported better sleep in hotels than did females, older people and subjects not suffering from insomnia, respectively. The factor which most frequently disturbed sleep in hotels was poor pillows, followed by high room temperature, poor mattress, poor duvet, noise from the street, poor indoor climate, too much daylight from the windows and noise from the ventilation system. Nearly 50% of the respondents reported that sleep usually improved with length of stay, whereas only 8.4% reported that sleep deteriorated with length of stay. The results point to several factors which could be altered by simple means and thereby improve sleep in hotels. The present study is the first large-scale survey that investigates how hotel guests in general experience sleep in hotels.
- Open Access
- 15 March 2015
- Published by Springer Nature in Substance Abuse Treatment, Prevention, and Policy
- Vol. 10 (1) , 1-19
Polypharmacy among anabolic-androgenic steroid users: a descriptive metasynthesis
As far as we are aware, no previous systematic review and synthesis of the qualitative/descriptive literature on polypharmacy in anabolic-androgenic steroid(s) (AAS) users has been published. We systematically reviewed and synthesized qualitative/descriptive literature gathered from searches in electronic databases and by inspecting reference lists of relevant literature to investigate AAS users’ polypharmacy. We adhered to the recommendations of the UK Economic and Social Research Council’s qualitative research synthesis manual and the PRISMA guidelines. A total of 50 studies published between 1985 and 2014 were included in the analysis. Studies originated from 10 countries although most originated from United States (n = 22), followed by Sweden (n = 7), England only (n = 5), and the United Kingdom (n = 4). It was evident that prior to their debut, AAS users often used other licit and illicit substances. The main ancillary/supplementary substances used were alcohol, and cannabis/cannabinoids followed by cocaine, growth hormone, and human chorionic gonadotropin (hCG), amphetamine/meth, clenbuterol, ephedra/ephedrine, insulin, and thyroxine. Other popular substance classes were analgesics/opioids, dietary/nutritional supplements, and diuretics. Our classification of the various substances used by AAS users resulted in 13 main groups. These non-AAS substances were used mainly to enhance the effects of AAS, combat the side effects of AAS, and for recreational or relaxation purposes, as well as sexual enhancement. Our findings corroborate previous suggestions of associations between AAS use and the use of other licit and illicit substances. Efforts must be intensified to combat the debilitating effects of AAS-associated polypharmacy.
- 15 March 2015
- Published by Springer Nature in Substance Abuse Treatment, Prevention, and Policy
- Vol. 10 (1) , 1-19
Open AccessPolypharmacy among anabolic-androgenic steroid users: a descriptive metasynthesis
As far as we are aware, no previous systematic review and synthesis of the qualitative/descriptive literature on polypharmacy in anabolic-androgenic steroid(s) (AAS) users has been published. We systematically reviewed and synthesized qualitative/descriptive literature gathered from searches in electronic databases and by inspecting reference lists of relevant literature to investigate AAS users’ polypharmacy. We adhered to the recommendations of the UK Economic and Social Research Council’s qualitative research synthesis manual and the PRISMA guidelines. A total of 50 studies published between 1985 and 2014 were included in the analysis. Studies originated from 10 countries although most originated from United States (n = 22), followed by Sweden (n = 7), England only (n = 5), and the United Kingdom (n = 4). It was evident that prior to their debut, AAS users often used other licit and illicit substances. The main ancillary/supplementary substances used were alcohol, and cannabis/cannabinoids followed by cocaine, growth hormone, and human chorionic gonadotropin (hCG), amphetamine/meth, clenbuterol, ephedra/ephedrine, insulin, and thyroxine. Other popular substance classes were analgesics/opioids, dietary/nutritional supplements, and diuretics. Our classification of the various substances used by AAS users resulted in 13 main groups. These non-AAS substances were used mainly to enhance the effects of AAS, combat the side effects of AAS, and for recreational or relaxation purposes, as well as sexual enhancement. Our findings corroborate previous suggestions of associations between AAS use and the use of other licit and illicit substances. Efforts must be intensified to combat the debilitating effects of AAS-associated polypharmacy.
- Open Access
- 8 February 2015
- Published by SAGE Publications in Nordic Studies on Alcohol and Drugs
- Vol. 32 (1) , 7-20
Anabolic-Androgenic Steroid use in the Nordic Countries: A Meta-Analysis and Meta-Regression Analysis
Aims: To investigate the lifetime prevalence and moderators of non-medical AAS use in the five Nordic countries. Methods: We conducted a meta-analysis and meta-regression using studies gathered from searches in PsycINFO, PubMed, ISI Web of Science, Google Scholar, and reference checks. Included were 32 studies that provided original data on 48 lifetime prevalence rates based on a total of 233,475 inhabitants of the Nordic countries. Results: – The overall lifetime prevalence obtained was 2.1% [95% confidence interval (CI): 1.3-3.4, I2 = 99.5, P < 0.001]. The prevalence for males, 2.9% (95% CI: 1.7-4.8, I2 = 99.2, P < 0.001), was significantly higher (Qbet = 40.5, P < 0.001) than the rate for females, 0.2% (95% CI: 0.1-0.4, I2 = 90.5, P < 0.001). Sweden has the highest prevalence of AAS use: 4.4%, followed by Norway: 2.4%, Finland: 0.8%, Iceland: 0.7%, and Denmark: 0.5%. Country, sample type, and male sample percentage significantly predicted AAS use prevalence in a meta-regression analysis. No indication of publication bias was found. Conclusion: – Though subject to some limitations, our findings suggest that non-medical AAS use should be regarded as a serious public health problem in the Nordic countries.
- 8 February 2015
- Published by SAGE Publications in Nordic Studies on Alcohol and Drugs
- Vol. 32 (1) , 7-20
Open AccessAnabolic-Androgenic Steroid use in the Nordic Countries: A Meta-Analysis and Meta-Regression Analysis
Aims: To investigate the lifetime prevalence and moderators of non-medical AAS use in the five Nordic countries. Methods: We conducted a meta-analysis and meta-regression using studies gathered from searches in PsycINFO, PubMed, ISI Web of Science, Google Scholar, and reference checks. Included were 32 studies that provided original data on 48 lifetime prevalence rates based on a total of 233,475 inhabitants of the Nordic countries. Results: – The overall lifetime prevalence obtained was 2.1% [95% confidence interval (CI): 1.3-3.4, I2 = 99.5, P < 0.001]. The prevalence for males, 2.9% (95% CI: 1.7-4.8, I2 = 99.2, P < 0.001), was significantly higher (Qbet = 40.5, P < 0.001) than the rate for females, 0.2% (95% CI: 0.1-0.4, I2 = 90.5, P < 0.001). Sweden has the highest prevalence of AAS use: 4.4%, followed by Norway: 2.4%, Finland: 0.8%, Iceland: 0.7%, and Denmark: 0.5%. Country, sample type, and male sample percentage significantly predicted AAS use prevalence in a meta-regression analysis. No indication of publication bias was found. Conclusion: – Though subject to some limitations, our findings suggest that non-medical AAS use should be regarded as a serious public health problem in the Nordic countries.
- Open Access
- 8 February 2015
- Published by SAGE Publications in Nordic Studies on Alcohol and Drugs
- Vol. 32 (1) , 27-30
Anabolic Androgenic Steroid use in the Nordic Countries: A Reply to Bilgrei and Sand⊘y
References Section: Choose Top of page References << Bilgrei, O. R., & Sand⊘y, T. A. (2015). Should the use of anabolic-androgenic steroids be considered a major public health problem in the Nordic countries? A commentary on Sagoe et al. (2015). Nordic Studies on Alcohol and Drugs, 32(1), 25–26. Google Scholar , Abstract Cunningham, R. L., Lumia, A. R., & McGinnis, M. Y. (2013). Androgenic anabolic steroid exposure during adolescence: Ramifications for brain development and behavior. Hormones and Behavior, 64, 350–356. Google Scholar Hildebrandt, T., Langenbucher, J. W., Flores, A., Harty, S., & Berlin, H. (2014). The influence of age of onset and acute anabolic steroid exposure on cognitive performance, impulsivity, and aggression in men. Psychology of Addictive Behaviors, 28, 1096–1104. Google Scholar Jenssen, I. H., & Johannessen, K. B. (2015). Aggression and body image concerns among anabolic androgenic steroid users, contemplators, and controls in Norway. Body Image, 12, 6–13. Google Scholar Kanayama, G., Hudson, J. I., & Pope,, H. G. (2009a). Features of men with anabolic-androgenic steroid dependence: A comparison with nondependent AAS users and with AAS nonusers. Drug and Alcohol Dependence, 102, 130–137. Google Scholar Kicman, A. T., & Gower, D. B. (2003). Anabolic steroids in sport: Biochemical, clinical and analytical perspectives. Annals of Clinical Biochemistry, 40, 321–356. Google Scholar , Abstract Klötz, F., Garle, M., Granath, F., & Thiblin, I. (2006). Criminality among individuals testing positive for the presence of anabolic androgenic steroids. Archives of General Psychiatry, 63, 1274–1279. Google Scholar Klötz, F., Petersson, A., Isacson, D., & Thiblin, I. (2007). Violent crime and substance abuse: A medico-legal comparison between deceased users of anabolic androgenic steroids and abusers of illicit drugs. Forensic Science International, 173, 57–63. Google Scholar Landry, G. L., & Primos,, W. A. (1990). Anabolic steroid abuse. Advances in Pediatrics, 37, 185–205. Google Scholar Lundholm, L., Frisell, T., Lichtenstein, P., & Långström, N. (2014). Anabolic androgenic steroids and violent offending: Confounding by polysubstance abuse among 10,365 general population men. Addiction, doi: 10.1111/add.12715 Google Scholar Pagonis, T. A., Angelopoulos, N. V., Koukoulis, G. N., & Hadjichristodoulou, C. S. (2006). Psychiatric side effects induced by supraphysiological doses of combinations of anabolic steroids correlate to the severity of abuse. European Psychiatry, 21, 551–562. Google Scholar Pope,, H. G. & Kanayama, G. (2012). Anabolic-androgenic steroids. In Verster, J., Brady, K., Galanter, M., & Conrod, P. (Eds.), Drug abuse and addiction in medical illness: Causes, consequences and treatment (pp. 251–264). New York: Springer. Google Scholar Pope,, H. G. Kanayama, G., Athey, A., Ryan, E., Hudson, J. I., & Baggish, A. (2014). The lifetime prevalence of anabolic-androgenic steroid use and dependence in Americans: Current best estimates. American Journal on Addictions, 23, 371–377. Google Scholar Pope,, H. G. Kouri, E. M., & Hudson, J. I. (2000). Effects of supraphysiologic doses of testosterone on mood and aggression in normal men: A randomized controlled trial. Archives of General Psychiatry, 57, 133–140. Google Scholar Sagoe, D., Andreassen, C. S., & Pallesen, S. (2014). The aetiology and trajectory of anabolic-androgenic steroid use initiation: A systematic review and synthesis of qualitative research. Substance Abuse Treatment, Prevention, and Policy, 9, 27 doi: 10.1186/1747-597X-9-27 Google Scholar Sagoe, D., Torsheim, T., Molde, H., Andreassen, C. S., & Pallesen, S. (2015a). Anabolic-androgenic steroid use in the Nordic countries: A meta-analysis and meta-regression analysis. Nordic Studies on Alcohol and Drugs, 32(1), 7–20. Google Scholar , Abstract Sagoe, D., Huang, K., Molde, H., Andreassen, C. S., & Pallesen, S. (2015b). Perceived anabolic-androgenic steroid use is associated with perceived neuroticism. Journal of Substance Use, doi: 10.3109/14659891.2015.1009510 Google Scholar Sand⊘y, T. A. (2013). Anabole steroider i Norge. En oversikt fra befolkningsunders⊘kelser [Anabolic steroids in Norway. An overview of population studies]. Oslo: Statens Institutt for Rusmiddelforskning. Retrieved from http://www.sirus.no/filestore/Import_vedlegg/Vedlegg_publikasjon/sirusrap.4.13.pdf Google Scholar
- 8 February 2015
- Published by SAGE Publications in Nordic Studies on Alcohol and Drugs
- Vol. 32 (1) , 27-30
Open AccessAnabolic Androgenic Steroid use in the Nordic Countries: A Reply to Bilgrei and Sand⊘y
References Section: Choose Top of page References << Bilgrei, O. R., & Sand⊘y, T. A. (2015). Should the use of anabolic-androgenic steroids be considered a major public health problem in the Nordic countries? A commentary on Sagoe et al. (2015). Nordic Studies on Alcohol and Drugs, 32(1), 25–26. Google Scholar , Abstract Cunningham, R. L., Lumia, A. R., & McGinnis, M. Y. (2013). Androgenic anabolic steroid exposure during adolescence: Ramifications for brain development and behavior. Hormones and Behavior, 64, 350–356. Google Scholar Hildebrandt, T., Langenbucher, J. W., Flores, A., Harty, S., & Berlin, H. (2014). The influence of age of onset and acute anabolic steroid exposure on cognitive performance, impulsivity, and aggression in men. Psychology of Addictive Behaviors, 28, 1096–1104. Google Scholar Jenssen, I. H., & Johannessen, K. B. (2015). Aggression and body image concerns among anabolic androgenic steroid users, contemplators, and controls in Norway. Body Image, 12, 6–13. Google Scholar Kanayama, G., Hudson, J. I., & Pope,, H. G. (2009a). Features of men with anabolic-androgenic steroid dependence: A comparison with nondependent AAS users and with AAS nonusers. Drug and Alcohol Dependence, 102, 130–137. Google Scholar Kicman, A. T., & Gower, D. B. (2003). Anabolic steroids in sport: Biochemical, clinical and analytical perspectives. Annals of Clinical Biochemistry, 40, 321–356. Google Scholar , Abstract Klötz, F., Garle, M., Granath, F., & Thiblin, I. (2006). Criminality among individuals testing positive for the presence of anabolic androgenic steroids. Archives of General Psychiatry, 63, 1274–1279. Google Scholar Klötz, F., Petersson, A., Isacson, D., & Thiblin, I. (2007). Violent crime and substance abuse: A medico-legal comparison between deceased users of anabolic androgenic steroids and abusers of illicit drugs. Forensic Science International, 173, 57–63. Google Scholar Landry, G. L., & Primos,, W. A. (1990). Anabolic steroid abuse. Advances in Pediatrics, 37, 185–205. Google Scholar Lundholm, L., Frisell, T., Lichtenstein, P., & Långström, N. (2014). Anabolic androgenic steroids and violent offending: Confounding by polysubstance abuse among 10,365 general population men. Addiction, doi: 10.1111/add.12715 Google Scholar Pagonis, T. A., Angelopoulos, N. V., Koukoulis, G. N., & Hadjichristodoulou, C. S. (2006). Psychiatric side effects induced by supraphysiological doses of combinations of anabolic steroids correlate to the severity of abuse. European Psychiatry, 21, 551–562. Google Scholar Pope,, H. G. & Kanayama, G. (2012). Anabolic-androgenic steroids. In Verster, J., Brady, K., Galanter, M., & Conrod, P. (Eds.), Drug abuse and addiction in medical illness: Causes, consequences and treatment (pp. 251–264). New York: Springer. Google Scholar Pope,, H. G. Kanayama, G., Athey, A., Ryan, E., Hudson, J. I., & Baggish, A. (2014). The lifetime prevalence of anabolic-androgenic steroid use and dependence in Americans: Current best estimates. American Journal on Addictions, 23, 371–377. Google Scholar Pope,, H. G. Kouri, E. M., & Hudson, J. I. (2000). Effects of supraphysiologic doses of testosterone on mood and aggression in normal men: A randomized controlled trial. Archives of General Psychiatry, 57, 133–140. Google Scholar Sagoe, D., Andreassen, C. S., & Pallesen, S. (2014). The aetiology and trajectory of anabolic-androgenic steroid use initiation: A systematic review and synthesis of qualitative research. Substance Abuse Treatment, Prevention, and Policy, 9, 27 doi: 10.1186/1747-597X-9-27 Google Scholar Sagoe, D., Torsheim, T., Molde, H., Andreassen, C. S., & Pallesen, S. (2015a). Anabolic-androgenic steroid use in the Nordic countries: A meta-analysis and meta-regression analysis. Nordic Studies on Alcohol and Drugs, 32(1), 7–20. Google Scholar , Abstract Sagoe, D., Huang, K., Molde, H., Andreassen, C. S., & Pallesen, S. (2015b). Perceived anabolic-androgenic steroid use is associated with perceived neuroticism. Journal of Substance Use, doi: 10.3109/14659891.2015.1009510 Google Scholar Sand⊘y, T. A. (2013). Anabole steroider i Norge. En oversikt fra befolkningsunders⊘kelser [Anabolic steroids in Norway. An overview of population studies]. Oslo: Statens Institutt for Rusmiddelforskning. Retrieved from http://www.sirus.no/filestore/Import_vedlegg/Vedlegg_publikasjon/sirusrap.4.13.pdf Google Scholar
- Open Access
- 15 August 2014
- Published by Springer Nature in BMC Pediatrics
- Vol. 14 (1) , 204
Sleep and body mass index in adolescence: results from a large population-based study of Norwegian adolescents aged 16 to 19 years
The aim of this study was to examine the association between body mass index (BMI) and sleep duration, insomnia and symptoms of obstructive sleep apnea (OSA) in adolescents.
- 15 August 2014
- Published by Springer Nature in BMC Pediatrics
- Vol. 14 (1) , 204
Open AccessSleep and body mass index in adolescence: results from a large population-based study of Norwegian adolescents aged 16 to 19 years
The aim of this study was to examine the association between body mass index (BMI) and sleep duration, insomnia and symptoms of obstructive sleep apnea (OSA) in adolescents.
- Open Access
- 15 July 2014
- Published by Springer Nature in BMC Public Health
- Vol. 14 (1) , 720
Midlife insomnia and subsequent mortality: the Hordaland health study
Previous research suggests a possible link between insomnia and mortality, but findings are mixed and well-controlled studies are lacking. The aim of the current study was to examine the effect of insomnia in middle age on all-cause mortality.
- 15 July 2014
- Published by Springer Nature in BMC Public Health
- Vol. 14 (1) , 720
Open AccessMidlife insomnia and subsequent mortality: the Hordaland health study
Previous research suggests a possible link between insomnia and mortality, but findings are mixed and well-controlled studies are lacking. The aim of the current study was to examine the effect of insomnia in middle age on all-cause mortality.
- Open Access
- 2 July 2014
- Published by Springer Nature in Substance Abuse Treatment, Prevention, and Policy
- Vol. 9 (1) , 27
The aetiology and trajectory of anabolic-androgenic steroid use initiation: a systematic review and synthesis of qualitative research
To our knowledge, there has never been a systematic review and synthesis of the qualitative literature on the trajectory and aetiology of nonmedical anabolic-androgenic steroid (AAS) use.
- 2 July 2014
- Published by Springer Nature in Substance Abuse Treatment, Prevention, and Policy
- Vol. 9 (1) , 27
Open AccessThe aetiology and trajectory of anabolic-androgenic steroid use initiation: a systematic review and synthesis of qualitative research
To our knowledge, there has never been a systematic review and synthesis of the qualitative literature on the trajectory and aetiology of nonmedical anabolic-androgenic steroid (AAS) use.
- 1 February 2014
- Published by Elsevier in Sleep Medicine
- Vol. 15 (2) , 173-179
A 10-year trend of insomnia prevalence in the adult Norwegian population
- 1 February 2014
- Published by Elsevier in Sleep Medicine
- Vol. 15 (2) , 173-179
A 10-year trend of insomnia prevalence in the adult Norwegian population
- Open Access
- 16 January 2014
- Published by SAGE Publications in Nordic Studies on Alcohol and Drugs
Anabolic-androgenic Steroid Use in the Nordic Countries: A Meta-analysis and Meta-regression Analysis
AIMS – To investigate the lifetime prevalence and moderators of non-medical AAS use in the five Nordic countries. METHODS – We conducted a meta-analysis and meta-regression using studies gathered from searches in PsycINFO, PubMed, ISI Web of Science, Google Scholar, and reference checks. Included were 32 studies that provided original data on 48 lifetime prevalence rates based on a total of 233,475 inhabitants of the Nordic countries. RESULTS – The overall lifetime prevalence obtained was 2.1% [95% confidence interval (CI): 1.3-3.4, I 2 = 99.5, P < 0.001]. The prevalence for males, 2.9% (95% CI: 1.7-4.8, I 2 = 99.2, P < 0.001), was significantly higher (Q
- 16 January 2014
- Published by SAGE Publications in Nordic Studies on Alcohol and Drugs
Open AccessAnabolic-androgenic Steroid Use in the Nordic Countries: A Meta-analysis and Meta-regression Analysis
AIMS – To investigate the lifetime prevalence and moderators of non-medical AAS use in the five Nordic countries. METHODS – We conducted a meta-analysis and meta-regression using studies gathered from searches in PsycINFO, PubMed, ISI Web of Science, Google Scholar, and reference checks. Included were 32 studies that provided original data on 48 lifetime prevalence rates based on a total of 233,475 inhabitants of the Nordic countries. RESULTS – The overall lifetime prevalence obtained was 2.1% [95% confidence interval (CI): 1.3-3.4, I 2 = 99.5, P < 0.001]. The prevalence for males, 2.9% (95% CI: 1.7-4.8, I 2 = 99.2, P < 0.001), was significantly higher (Q